Results 51 to 60 of about 2,063,448 (396)

Natural Products as Geroprotective Modulators in Diabetic Nephropathy: A Mechanistic Framework Integrating Aging Hallmarks and the AMPK–SIRT1–Nrf2 Axis

open access: yesAging and Cancer, EarlyView.
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu   +8 more
wiley   +1 more source

Reperfusion‐Dependent Outcomes After Endovascular Thrombectomy Stratified by NIHSS‐ASPECTS Clinical‐Core Mismatch

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This analysis evaluates the effect of successful reperfusion on functional outcomes after MT, stratified by admission National Institutes of Health Stroke Scale (NIHSS) and Alberta Stroke Program Early CT Score (ASPECTS) as surrogates for clinical‐core mismatch, using multicenter registry data.
Felix Schlicht   +53 more
wiley   +1 more source

HIGH ANTIOXIDANT ACTIVITY AND CONSUMER-BASED SENSORY PROFILING OF MANGO LEAF HERBAL TEA USING SEVERAL BREWING METHODS [PDF]

open access: yesمجلة الأنبار للعلوم الزراعية
This study, conducted in Bogor, Indonesia from May-July 2024, evaluated the antioxidant activity and sensory characteristics of mango leaf herbal tea based on six tea-brewing techniques, i.e., soft infusion, hard infusion, ambient infusion, chilled green
A. Aminullah   +4 more
doaj   +1 more source

Effects of green tea and roasted green tea on human responses

open access: yesScientific Reports
Abstract Our objective was to elucidate the effects of tea consumption on refreshment and stress reduction/recovery through examining the multiple associations among factors such as various physiological responses and task performance.
Chie Kurosaka   +4 more
openaire   +3 more sources

Antioxidant Beverages: Green Tea Intake and Coronary Artery Disease

open access: yes, 2014
Coronary artery disease (CAD) is recognized as an inflammatory disease. In the present study, we investigated the effect of green tea consumption on plasma inflammatory markers and the association between green tea consumption and CAD.
Yukihiko Momiyama   +2 more
core   +1 more source

A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy

open access: yesNutrients, 2019
Tea is one of the most widely consumed beverages worldwide, and is available in various forms. Green tea is richer in antioxidants compared to other forms of tea.
M. Prasanth   +3 more
semanticscholar   +1 more source

Green tea processing by pan-firing from region-specific tea (Camellia sinensis L.) cultivars - a novel approach to sustainable tea production in Dooars region of North Bengal

open access: yesFood Chemistry Advances, 2023
: The black crush-tear-curl (CTC) tea constitutes the bulk tea production in Dooars region of North Bengal while green tea processing is confined to fewer tea estates, however, recent trends of the tea industry indicate gradual inclination towards green ...
Biplab Adhikary   +7 more
doaj   +1 more source

Green tea and neurodegeneration in Alzheimer's disease

open access: yes, 2013
Alzheimer’s disease (AD) is a progressive neurodegenerative disease which remains the major health concern among the elderly, and even the middle-aged population. The pathological changes in AD start well before the cognitive dysfunction.
Clara Hiu-Ling Hung   +5 more
core   +1 more source

HLA-B*35:01 and Green Tea Induced Liver Injury

open access: yesHepatology, 2020
Herbal supplements, and particularly multi‐ingredient products, have become increasingly common causes of acute liver injury. Green tea is a frequent component in implicated products, but its role in liver injury is controversial.
J. Hoofnagle   +18 more
semanticscholar   +1 more source

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy